Skip to main content
. 2021 Mar 3;9(3):e21061. doi: 10.2196/21061

Table 1.

Summary of meta-analysis resultsa.

Outcomes or subgroups Number of studies (N=25), n (%) Participants Statistical methods Effect estimates (95% CI) P value
BMI 10 (40) 2558 MDb (IV, random, 95% CI) −0.37 (−1.20 to 0.46) .38
Total cholesterol 9 (36) 1783 SMDc (IV, random, 95% CI) −0.29 (−0.44 to −0.15) <.001
High-density lipoprotein 9 (36) 1783 SMD (IV, random, 95% CI) −0.09 (−0.19 to 0.00) .05
Low-density lipoprotein 12 (48) 3431 SMD (IV, random, 95% CI) −0.18 (−0.33 to −0.04) .01
Triglycerides 8 (32) 1660 SMD (IV, random, 95% CI) −0.07 (−0.24 to 0.11) .28
Diastolic BPd 11 (44) 2460 SMD (IV, random, 95% CI) −0.06 (−0.20 to 0.08) .43
Systolic BP 12 (48) 3283 SMD (IV, random, 95% CI) −0.03 (−0.18 to 0.13) .74
Physical activity 14 (56) 3015 SMD (IV, random, 95% CI) 0.23 (0.11 to 0.36) <.001
Alcohol consumption 4 (16) 651 SMD (IV, random, 95% CI) −0.16 (−1.43 to 1.10) .80
Blood sugar, HbA1ce 2 (8) 380 RRf (M-H, random, 95% CI) 1.04 (0.40 to 2.70) .94
Physical inactivity 4 (16) 1054 RR (M-H, random, 95% CI) 0.54 (0.39 to 0.75) <.001
Food intake (diet) 6 (24) 716 RR (M-H, random, 95% CI) 0.79 (0.66 to 0.94) .007
Health diet 3 (12) 173 RR (M-H, random, 95% CI) 0.70 (0.55 to 0.89) .004
Unhealthy diet 3 (12) 185 RR (M-H, random, 95% CI) 0.90 (0.68 to 1.19) .47
Smoking 11 (44) 2916 RR (M-H, random, 95% CI) 0.87 (0.67 to 1.13) .30
Medication adherence 11 (44) 2710 RR (M-H, random, 95% CI) 1.10 (1.00 to 1.22) .06
Medication adherence (multiple treatment) 5 (20) 758 RR (M-H, random, 95% CI) 1.07 (1.01 to 1.14) .02

aSummary of analyzed data.

bMD: mean difference.

cSMD: standard mean difference.

dBP: blood pressure.

eHbA1c: Hemoglobin A1c blood sugar.

fRR: risk ratio.